Skip to main content

Will the Biotech Space Consolidate in the Back Half of the Year?

Industry analysts continue to posit that biotechnology consolidation is poised to accelerate through year-end – a scenario that could propel the ALPS Medical Breakthroughs ETF (SBIO) further forward. While there’s frequent chatter about biotechnology mergers and acquisitions, particularly...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.